Top-News
Dienstag,
19.09.2017 22:10
von
PR Newswire
| Aufrufe: 173
Luminex Corporation To Present At Cantor Fitzgerald's Global Healthcare Conference
Cloud-Computing überträgt Daten zwischen Geräten. (Symbolbild).
© PeopleImages / E+
PR Newswire
AUSTIN, Texas, Sept. 19, 2017
AUSTIN, Texas, Sept. 19, 2017 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at Cantor Fitzgerald's Global Healthcare Conference to be held September 25 -27, 2017, in New York, NY.
The investor presentation will begin at 10:20 a.m. Eastern time on Tuesday, September 26, 2017. The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.
ABOUT LUMINEX CORPORATION
Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.
| Contacts: | Harriss T. Currie |
| | Sr. Vice President, Finance and CFO |
| | 512-219-8020 |
| | |
| | |
| | Matt Scalo |
| | Sr. Director, Investor Relations |
| | 512-219-8020 |
| |
View original content with multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-to-present-at-cantor-fitzgeralds-global-healthcare-conference-300522168.html
SOURCE Luminex Corporation
Werbung
Mehr Nachrichten zur Luminex Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
